Skip to content
— CH. 1 · INTRODUCTION —

Amy Finkelstein

6 min listen · Ch. 1 of 6
6 sections
  • Amy Finkelstein wanted to know whether health insurance actually made people healthier. It sounds like an obvious question. But for decades, economists could not answer it with rigor. The data was tangled, the variables were uncontrolled, and the ethical barriers to running a true experiment on people's medical coverage seemed insurmountable. Then Oregon stumbled into a natural experiment that changed everything, and Finkelstein was ready to catch it.

    Born on the 2nd of November 1973 in New York City, Finkelstein grew up with two biologist parents who had both earned doctorates at The Rockefeller University. That household shaped something in her: a conviction that hard questions deserve hard evidence. She would carry that conviction from a Harvard classroom to the halls of MIT, and eventually into the real lives of low-income adults waiting for a lottery to determine whether they could see a doctor.

  • Finkelstein studied government, not economics, when she arrived at Harvard University. She graduated summa cum laude in 1995 with a BA, and earned a Truman Scholarship along the way. What redirected her toward economics was a single course: Lawrence Katz's "Social Problems in the American Economy". Katz was a Harvard economist, and his class showed Finkelstein how the tools of economics could be aimed directly at the social questions she cared about.

    She left Cambridge for Oxford as a Marshall Scholar and earned an M.Phil. in economics in 1997. Then she returned to MIT, where she completed her PhD in economics in 2001 under the supervision of James M. Poterba and Jonathan Gruber, both prominent figures in public finance. After a stint as a Junior Fellow at the Harvard Society of Fellows that lasted three years, she joined the MIT faculty in 2005. She received tenure within three years of joining, a notably swift rise.

    By 2016, MIT's School of Humanities, Arts, and Social Sciences named her the John and Jennie S. MacDonald Professor, a five-year term established through a gift by Edmund MacDonald.

  • In 2008, Oregon did something unprecedented. The state had more people eligible for Medicaid than it had slots available, so it held a lottery to assign coverage to uninsured, low-income adults. For health economists, this was the closest thing to a controlled experiment that had ever existed at this scale. Finkelstein, working alongside Katherine Baicker and a larger group of researchers, moved quickly to design and evaluate it as exactly that.

    The Oregon Health Insurance Experiment became the first large-scale, randomized, controlled study of Medicaid in the United States. The findings were striking. Newly covered enrollees made more overall visits to health-care providers, including more trips to emergency rooms. Their financial exposure dropped: catastrophic medical expenditures and medical debts fell among the newly insured. Self-reported health improved, and cases of depression declined among new Medicaid beneficiaries.

    Finkelstein said the body of work, including this Oregon expansion, made her confident that health insurance improves health. The publications that followed became among the most cited in contemporary health policy studies. The experiment's methodology also proved something at least as important as its clinical findings: that randomized designs could be applied to the large-scale study of public insurance programs, a possibility that had not been demonstrated before.

  • The timing of the Oregon experiment was not incidental to its influence. Its results fed directly into the national debate over Medicaid expansion that accelerated during and after the adoption of the Affordable Care Act. Finkelstein and Baicker served as the two principal investigators of the Oregon study, and the experiment transformed the empirical methodology of health economics as a field.

    Finkelstein's primary research focus sits at the intersection of public finance and health economics. She studies market failures and government intervention in insurance markets, and traces how public policy shapes health-care access and health outcomes. Her position as co-director of the NBER Health Care Program, a role she took on in 2020, placed her at the center of a program that had been launched in 2000 under Alan Garber to study markets for health care services, health insurance, and the provision of medical care. Garber later became provost of Harvard University.

    She also serves as co-Scientific Director of J-PAL North America, where she helps guide randomized evaluations of United States social policy, extending the experimental methods that shaped her Oregon work into a broader institutional setting.

  • In 2008, the Committee on the Status of Women in the Economics Profession awarded Finkelstein the Elaine Bennett Research Prize for her contributions to the discipline. Four years later, in 2012, the American Economic Association gave her the John Bates Clark Medal. The Clark Medal citation described her research as "a model of how theory and empirics can be combined in creative ways", a phrase that captures the dual-track approach she had been developing since her graduate training under Poterba and Gruber.

    In 2018, she received a MacArthur "Genius" Grant and was elected to the National Academy of Sciences. The MacArthur fellowship carries no prescribed agenda; its purpose is to free recipients to work on whatever they judge most important. For Finkelstein, that freedom pointed toward the same questions she had been asking since Lawrence Katz's course in Cambridge: what does government intervention in insurance markets actually do to people's lives?

  • Finkelstein is Jewish and was born in New York City. Both of her parents were biologists who earned doctorates at The Rockefeller University. Her mother immigrated to the United States from Poland in 1940, and her maternal grandmother had earned a doctorate in comparative literature at the University of Warsaw before that emigration. The layering of academic generations in her family is notable: grandmother, mother, and daughter each carrying a doctorate across different continents, different centuries, and different disciplines.

Common questions

What is Amy Finkelstein known for in economics?

Amy Finkelstein is best known for her work on the Oregon Health Insurance Experiment, the first large-scale randomized controlled study of Medicaid in the United States. She is a professor of economics at MIT and was awarded the John Bates Clark Medal in 2012 by the American Economic Association, which cited her research as a model of combining theory and empirics.

What did the Oregon Health Insurance Experiment find?

The Oregon Health Insurance Experiment found that newly enrolled Medicaid patients made more overall visits to health-care providers, including more emergency room visits, and experienced reduced financial burdens from catastrophic medical expenses and medical debts. The study also reported improved self-reported health and fewer cases of depression among new Medicaid beneficiaries.

What awards has Amy Finkelstein won?

Finkelstein received the Elaine Bennett Research Prize in 2008, the John Bates Clark Medal from the American Economic Association in 2012, and a MacArthur "Genius" Grant in 2018. She was also elected to the National Academy of Sciences in 2018.

Where did Amy Finkelstein go to school?

Finkelstein earned a BA in government from Harvard University in 1995, graduating summa cum laude as a Truman Scholar. She then studied at Oxford University as a Marshall Scholar, receiving an M.Phil. in economics in 1997. She completed her PhD in economics at MIT in 2001 under supervisors James M. Poterba and Jonathan Gruber.

What positions does Amy Finkelstein hold at MIT and NBER?

Finkelstein is a professor of economics at MIT and held the John and Jennie S. MacDonald Professor chair from 2016 for a five-year term. At the National Bureau of Economic Research, she serves as co-director and research associate of the Public Economics Program, and became co-director of the NBER Health Care Program in 2020.

How did the Oregon Medicaid lottery become a research experiment?

Beginning in 2008, Oregon used a lottery to assign limited Medicaid slots to uninsured low-income adults because demand exceeded availability. Finkelstein and Katherine Baicker recognized this as a natural experiment and designed a rigorous evaluation, making it the first large-scale randomized controlled study of Medicaid in the United States.

All sources

21 references cited across the entry

  1. 3NewsMIT economics professor awarded Bates Clark medalThe Boston Globe — 28 April 2012
  2. 5JournalAmy Finkelstein: 2012 John Bates Clark MedalistJonathan Levin et al. — 2012
  3. 8NewsA healthy understandingPeter Dizikes — April 15, 2020
  4. 10Amy Finkelstein – Short BiographyMassachusetts Institute of Technology
  5. 14JournalThe Effects of Medicaid Coverage — Learning from the Oregon ExperimentKatherine Baicker et al. — 2011
  6. 15JournalEffect of Medicaid Coverage on ED Use — Further Evidence from Oregon's ExperimentAmy Finkelstein et al. — 2016
  7. 18Testing their patientsMIT News — May 2017
  8. 20CSWEP Awards and PrizesCommittee on the Status of Women in the Economics Profession
  9. 22JournalProfile of Amy N. FinkelsteinJennifer Viegas — PNAS — 2020